Myelopathy Clinical Trial
Official title:
Role of Diffusion Tensor Imaging in Evaluation of Myelopathy
Myelopathy describes any neurologic deficit related to the spinal cord. Myelopathy is caused
by various pathological states of the human spinal cord, including tumors, inflammatory
lesions, spinal cord compression and degenerative myelopathy. Clinically, the diagnosis of
myelopathy depends on localization of the neurologic finding to the spinal cord, rather than
the brain or peripheral nervous system and then to a particular segment of the spinal cord.
Magnetic resonance imaging (MRI) plays an essential role in the diagnosis and follow-up of
the lesions of the spinal cord using conventional MRI T1- and T2-weighted sequences.
Sometimes a studied spinal cord may appear normal on conventional MRI even though patients
have symptoms of myelopathy causing a discrepancy between MRI findings and clinical findings.
Diffusion tensor imaging (DTI) is an advanced non-invasive MR imaging technique which
assesses the microstructural integrity of nerve fiber tracts.
A number of 70 patient with myelopathy included within the study.
DTI is used primarily for assessing white matter of the brain and spinal cord. DTI can depict
alterations to the white matter tract and quantify these changes. Disturbances of diffusion
(restriction or increase) may be assessed quantitatively by measurements of apparent
diffusion coefficient (ADC). The apparent diffusion coefficient (ADC), is used to measure
diffusive strength. Diffusion anisotropy can be assessed quantitatively by using the
fractional anisotropy (FA) parameter, which may be also visualized on fractional anisotropy
maps. FA is considered as a marker of white matter integrity.
Image acquisition will be conducted on a 1.5-Tesla MR scanner.
The imaging will be done throughout the following sequences:
1. Conventional MRI sequences: sagittal T1W, sagittal and axial T2W sequences.
2. DTI sequence: Single-shot spin-echo echo-planar imaging (EPI) and parallel imaging
techniques to achieve motion-free and higher signal-to-noise ratio (SNR) DTI.
Post processing:
The diffusion-tensor imaging data is transferred to an offline workstation utilizing software
used for reconstruction of the Diffusion Tensor imaging (DTI) with regions of interest were
defined and measured on the ADC and fractional anisotropy (FA) maps. diffusion tensor
tractogram will be constructed on the acquired data source.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00344890 -
Safety Study of Preservon-Treated Bone Implants for Cervical Fusion in the Treatment of Cervical Radiculopathy or Myelopathy
|
N/A | |
Not yet recruiting |
NCT05217498 -
Combining Low Oxygen Therapy and an Adenosine A2a Receptor Antagonist to Improve Functional Mobility After Spinal Cord Injury
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT01911013 -
A Study of Korean Society of Spine Surgery on the Outcomes of Anterior Cervical Discectomy and Fusion
|
N/A | |
Recruiting |
NCT03644407 -
Galeazzi Spine Surgery RegistryGaleazzi Spine Registry: Prospective Study for Clinical Monitoring
|
||
Withdrawn |
NCT03327272 -
Impact of Local Steroid Application in Extreme Lateral Lumbar Interbody Fusion
|
Phase 3 | |
Not yet recruiting |
NCT02059798 -
Urinary and Sexual Function Before and After Surgical Decompression of Cervical Myelopathy
|
N/A | |
Withdrawn |
NCT03518164 -
Comparing Allograft to Autograft Bone in ACDF Surgeries
|
N/A | |
Completed |
NCT03295617 -
Management of Giant Thoracic Disc Hernias by Thoracoscopy: Experience of 52 Cases
|
N/A | |
Terminated |
NCT03062657 -
An Investigation of the Metal Concentration in Patients Implanted With the PRESTIGE LP™ Cervical Disc at Two Contiguous Levels in the Cervical Spine
|
N/A | |
Completed |
NCT00637156 -
Study of the Safety and Effectiveness of the Artificial Cervical Disc - Low Profile Device at Two Adjacent Levels
|
N/A | |
Completed |
NCT00437190 -
Pivotal IDE Study of the BRYAN(R) Cervical Disc Prosthesis in the Treatment of DDD Versus ACDF
|
N/A | |
Terminated |
NCT01458938 -
This Study is to Determine if Degenerative Spinal Pain and Disorders Cause the Levels of Substance P to Change in a Patients Saliva, Blood and/or Cerebrospinal Fluid.
|
N/A | |
Recruiting |
NCT03556137 -
PET/MRI in the Diagnosis of Chronic Pain
|
Phase 1 | |
Terminated |
NCT02403453 -
RHINE™ Cervical Disc Clinical Study: A Prospective Observational Study for Patients Requiring 1-2 Level C-spine Surgery
|
||
Completed |
NCT00578812 -
PCM Cervical Disc System
|
Phase 3 | |
Recruiting |
NCT06464744 -
Efficacy of rTMS Treatment After Spinal Cord Injury
|
N/A | |
Recruiting |
NCT05257330 -
Evaluation of Non-Compressive Myelopathy in a Sample of Egyptian Patients
|
||
Completed |
NCT03591497 -
Role of Virtual Reality in Improving Balance in Patients With Myelopathy
|
N/A | |
Recruiting |
NCT04631471 -
Regeneration in Cervical Degenerative Myelopathy
|
Phase 3 | |
Completed |
NCT01511445 -
Interbody Fusion Devices in the Treatment of Cervicobrachial Syndrome
|
N/A |